InvestorsObserver
×
News Home

Do Analysts Agree Monday on FibroGen Inc (FGEN) Stock's Target Price?

Monday, May 23, 2022 02:54 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Monday on FibroGen Inc (FGEN) Stock's Target Price?

InvestorsObserver is giving FibroGen Inc (FGEN) an Analyst Rating Rank of 4, meaning FGEN is ranked higher by analysts than 4% of stocks. The average price target for FGEN is $14.5 and analyst’s rate the stock as a Hold.

Overall Score - 3
Wall Street analysts are rating FGEN a Hold today. Find out what this means to you and get the rest of the rankings on FGEN!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With FibroGen Inc Stock Today?

FibroGen Inc (FGEN) stock is trading at $8.77 as of 2:53 PM on Monday, May 23, an increase of $0.17, or 1.98% from the previous closing price of $8.60. The stock has traded between $8.29 and $8.83 so far today. Volume today is light. So far 547,815 shares have traded compared to average volume of 973,770 shares. Click Here to get the full Stock Report for FibroGen Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App